MOS
FLNA

MGO One Seven’s Filana Therapeutics FLNA Stock Holding History

MGO One Seven’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.7K Buy
33,339
+13,513
+68% +$19.3K ﹤0.01% 1540
2026
Q1 		$33.5K Sell
19,826
-1,436
-7% -$2.96K ﹤0.01% 1396
2025
Q4 		$42.1K Buy
21,262
+4,623
+28% +$14.8K ﹤0.01% 1384
2025
Q3 		$48.4K Sell
16,639
-118
-0.7% -$271 ﹤0.01% 1314
2025
Q2 		$30.3K Buy
16,757
+1,309
+8% +$2.33K ﹤0.01% 1188
2025
Q1 		$23.2K Buy
15,448
+127
+0.8% +$320 ﹤0.01% 1088
2024
Q4 		$36.2K Buy
15,321
+327
+2% +$5.74K ﹤0.01% 1059
2024
Q3 		$441K Buy
14,994
+2,117
+16% +$48.8K 0.02% 625
2024
Q2 		$159K Buy
+12,877
New +$271K 0.01% 923
2022
Q4 		– Sell
-5,432
Closed -$227K – 779
2022
Q3 		$227K Buy
+5,432
New +$147K 0.01% 616

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

MGO One Seven's FLNA Position: Q2 2026 in Review

MGO One Seven increased its Filana Therapeutics (FLNA) stake by 68% in Q2 2026, buying an estimated $19.3K and bringing the position to 33,339 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

MGO One Seven first reported a position in FLNA in Q3 2022 and has held it in 10 quarters since. The position peaked at $441K in Q3 2024. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • MGO One Seven held 33,339 shares of Filana Therapeutics worth $39.7K as of Q2 2026.
  • MGO One Seven bought 13,513 Filana Therapeutics shares in Q2 2026, an estimated $19.3K.
  • Filana Therapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1540 holding.
  • MGO One Seven first reported a position in Filana Therapeutics in Q3 2022 and has held it in 10 quarters since.
  • MGO One Seven's Filana Therapeutics position peaked at $441K in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.